Public Calendar: August 9-15, 2020
This public calendar is issued by the Food and Drug Administration. It lists significant meetings held by designated FDA policy makers with persons outside the executive branch of the federal government.
Official Name: Stephen M. Hahn, M.D., Commissioner of Food and Drugs
Event Date: 08/10/2020
Location: Teleconference
Subject: The Critical Role of Health Care Professionals During the COVID-19 Pandemic
FDA Participant/Group: DAYLE CRISTINZIO; COLIN ROM;
Non FDA Participant/Group: Several members of health care professional groups and government
Event Date: 08/12/2020
Location: Virtual
Subject: Center for Drug Evaluation and Research Scientific Rounds
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Industry, government, and other registered guests
Event Date: 08/13/2020
Location: Boise, ID
Subject: Roundtable on COVID-19 Efforts
FDA Participant/Group: COLIN ROM;
Non FDA Participant/Group: Idaho state, local, tribal, and public health officials
Official Name: Amy Abernethy, M.D., Ph.D, Principal Deputy Commissioner
Event Date: 08/11/2020
Location: Virtual
Subject: Drug Information Association (DIA) DIRECT Webinar: Real-World Data to Inform COVID-19 Response: Collaborating in the COVID-19 Evidence Accelerator
FDA Participant/Group: N/A
Non FDA Participant/Group: Academia, industry, patients, federal government, and other stakeholders
Event Date: 08/14/2020
Location: Virtual
Subject: Technology Modernization Listening Session with Association of Clinical Research Organizations (ACRO)
FDA Participant/Group: LAURA ROE; RICHARD FORSHEE; DIANE MALONEY; PHILIP BUDASHEWITZ; RAM IYER; MIMI NGUYEN; JOSEPH FRANKLIN;
Non FDA Participant/Group: Doug Peddicord, Elyssa Clauson, Karen Noonan (Association of Clinical Research Organizations (ACRO)); Niklas Morton (PPD); Michelle Hoiseth (Parexel); Srivatsan Nagaraja (IQVIA); Jonathan Shough (Covance); Henry Levy (Veeva); Lawrence Miller (Signant Health); Jim Streeter (Oracle); Don Ragas (ERT); Ari Feldman (Medidata);
Official Name: Anand Shah, M.D., Deputy Commissioner for Medical and Scientific Affairs
No Significant Event
Official Name: Anna Abram, Deputy Commissioner for Policy, Legislation, and International Affairs
No Significant Event
Official Name: Jim Sigg, Deputy Commissioner for Operations
No Significant Event
Official Name: Frank Yiannas, Deputy Commissioner for Food Policy and Response
Event Date: 08/12/2020
Location: Virtual
Subject: Produce Safety Issues of Mutual Interest
FDA Participant/Group: Several FDA staff
Non FDA Participant/Group: Several Arizona industry executives, state government officials, and academia
Event Date: 08/13/2020
Location: Virtual
Subject: Food Safety Issues of Mutual Interest
FDA Participant/Group: N/A
Non FDA Participant/Group: Danny Wegman, Dave Corsi , Gillian Kelleher (Wegmans);
Official Name: Lowell Schiller, Principal Associate Commissioner for Policy
No Significant Event
Official Name: Mark Abdoo, Associate Commissioner for Global Policy and Strategy
No Significant Event
Official Name: Judy McMeekin, Associate Commissioner for Regulatory Affairs
No Significant Event
Official Name: John Wagner, Associate Commissioner for External Affairs
No Significant Event
Official Name: RADM Denise Hinton, Chief Scientist
No Significant Event
Official Name: Patrizia Cavazzoni, M.D., Acting Director, Center for Drug Evaluation and Research
No Significant Event
Official Name: Peter Marks, M.D., Ph.D., Director, Center for Biologics Evaluation and Research
No Significant Event
Official Name: Jeffrey Shuren, M.D., J.D., Director, Center for Devices and Radiological Health
No Significant Event
Official Name: Mitchell R. Zeller, J.D., Director, Center for Tobacco Products
No Significant Event
Official Name: Steven Solomon, Director, Center for Veterinary Medicine
No Significant Event
Official Name: William Slikker, Jr., Ph.D., Director, National Center for Toxicological Research
No Significant Event
Official Name: Stacy Cline Amin, Chief Counsel
No Significant Event